XILIS INC
Durham, NC · Founded 2019 · CIK 0001796056 · Medtech · Private
MOSgen instrument that rapidly generates micro-organospheres from patient tumor samples for functional precision oncology testing
xilis.net →- Grants
- $4.2M
- 6 awards
- Sector median: 1
- Raised
- $109M
- 4 Form D · Apr 2025
- 17 months since last filing
- Contracts
- $225K
- 1 award · Defense
- #450 of 4531 in medtech
- Patents
- 25
- 10 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,999,999 | |
| Federal contract | Department of Defense · Tissue-derived Droplet Micro-organospheres As Models For High-throughput Testing Of Pathogens | $224,658 | |
| Private capital raised | Form D · SEC | $70,000,006 | |
| Federal grant | Department of Health and Human Services · Phase II · Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy | $398,486 | |
| Private capital raised | Form D · SEC | $16,514,618 | |
| Federal grant | Department of Health and Human Services · Phase II · Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy | $998,506 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · An integrated microfluidic device for patient-derived micro-organospheres | $399,738 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · An integrated microfluidic device for patient-derived micro-organospheres | $399,738 | |
| Federal grant | Department of Health and Human Services · Phase II · An integrated microfluidic device for patient-derived micro-organospheres | $1,239,153 | |
| Private capital raised | Form D · SEC | $19,405,205 | |
| Federal grant | Department of Health and Human Services · Phase II · An integrated microfluidic device for patient-derived micro-organospheres | $758,547 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 447 | HealthMyne, Inc. | $225K | $19M |
| 448 | DETON CORP | $225K | — |
| 449 | NANOHYBRIDS INC | $225K | — |
| 450 | XILIS INC | $225K | $109M |
| 451 | PBS Biotech, Inc. | $224K | $43M |
| 452 | NIGHTWARE, INC | $213K | $2.5M |
| 453 | NEW SCALE TECHNOLOGIES, INC | $207K | $784K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Halawa AlaaDirector · Executive Officer
- Wesley ChanDirector · Executive Officer
- John de KoningDirector
- Alaa HalawaDirector
- David HsuDirector · Executive Officer
- Xiling ShenDirector · Executive Officer · Promoter
- David ShiaowenDirector
- William SmytheDirector · Executive Officer
Patents
- Multiple Myeloma Microorganospheresapplication
- Methods Of Delivering Components To Microorganospheresapplication
- Methods And Apparatuses For Testing Hepatocyte Toxicity Using Microorganospheresapplication
- Integrated Microfluidic System For Generation Of Dropletsgranted
- Closed Loop Control Of Microfluidic Systemsapplication
- Integrated Microfluidic System For Generation Of Dropletsgranted
- Closed Loop Control Of Microfluidic Systemsgranted
- Closed Loop Control Of Microfluidic Systemsgranted
- Imaging-based Droplet Drug Assaysapplication
- Measurement And Control Of Droplet Sizesapplication
- Methods And Apparatus For Testing Immuno-oncology Drugs And Biologics Using Microorganospheresapplication
- Integrated Microfluidic System For Generation Of Dropletsgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.